Dr. Lal Pathlabs Ltd. (LALPATHLAB): Dr. Lal Pathlabs Share Price Rises 4.08% Today

Dr. Lal Pathlabs Share Price rises 4.08% today, reaching Rs 1,880 with a market cap of Rs 30,607.3 Cr.

Dr. Lal Pathlabs Share Price has witnessed a notable increase of 4.08% today, closing at Rs 1,880. This rise comes as the stock opened at Rs 1,808.95 and reached a high of Rs 1,892 during the trading session. With a market capitalisation of Rs 30,607.3 crore, Dr. Lal Pathlabs is classified as a Large Cap company. While the data confirms the price event, it does not establish a company-specific catalyst for this movement. Investors are keen to understand the underlying factors contributing to this price action.

Dr. Lal Pathlabs Ltd. (LALPATHLAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,880
Previous Close	Rs 1,806.25
Today's Change	+Rs 73.75 (+4.08%)
Day Open	Rs 1,808.95
Day High	Rs 1,892
Day Low	Rs 1,803.95
Current Volume (BSE)	41,788
BSE Traded Volume	41,788
NSE Traded Volume	10,40,059
Combined NSE + BSE Volume	10,81,847
Turnover	Rs 7.86 crore
Market Capitalisation	Rs 30,607.3 crore
Market Cap Category	Large Cap

Dr. Lal Pathlabs Ltd. (LALPATHLAB) traded at Rs 1,880. versus the previous close of Rs 1,806.25, a rise of 4.08%. The stock opened at Rs 1,808.95, reached Rs 1,892, touched Rs 1,803.95. Reported volume was 41,788.

Dr. Lal Pathlabs Ltd. (LALPATHLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 30,607.3 crore

Dr. Lal Pathlabs, with a market capitalisation of Rs 30,607.3 crore, operates within the healthcare sector. The company's valuation metrics, such as P/E and P/B ratios, are crucial for investors assessing its financial health. The sector's P/E median is 26.44, while the average is significantly higher at 87.62, indicating a wide range of valuations among peers. The P/B median for the sector is 1.9, with an average of 2.55. These figures provide a context for evaluating Dr. Lal Pathlabs' valuation relative to its peers. The company's financial performance, including ROE and ROCE, is essential for understanding its profitability and efficiency. With the sector's ROE median at 11.07% and ROCE median at 13.24%, Dr. Lal Pathlabs' performance can be benchmarked against these figures. Investors should consider these fundamentals when analyzing the stock's potential.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.44x
Benchmark Average P/E	87.62x
Benchmark P/E Range	3.61x to 3,439.3x
Benchmark Median P/B	1.9x
Benchmark Median ROE	11.07%
Benchmark Median ROCE	13.24%
Company Market Capitalisation	Rs 30,607.3 crore
Benchmark Median Market Cap	Rs 140.64 crore

Dr. Lal Pathlabs Ltd. (LALPATHLAB) is classified under sector: Healthcare.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Dr. Lal Pathlabs operates within the healthcare sector, which comprises 198 companies. The sector's P/E ratio ranges from a minimum of 3.61 to a maximum of 3439.3, with a median of 26.44. This wide range reflects the diverse nature of companies within the sector. The P/B ratio varies from -16.79 to 16.32, with a median of 1.9. The sector's ROE and ROCE medians are 11.07% and 13.24%, respectively, indicating the average profitability and efficiency of companies in this space. Dr. Lal Pathlabs' market capitalisation of Rs 30,607.3 crore positions it among the larger players in the sector. Understanding these sector dynamics is crucial for investors assessing the company's competitive position and growth prospects.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,921.65	29.31	0.43	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,815.27	39.89	8.12	28.21	26.35
Hikal Ltd.	HIKAL	2,738.51	0	2.23	15.22	16.15
Panacea Biotec Ltd.	PANACEABIO	2,653.99	0	3.04	0	5.36
Sai Parenteral's Ltd.	SAIPARENT	2,476.69	169.37	3.13	13.9	12.97

Dr. Lal Pathlabs Ltd. (LALPATHLAB) has a market capitalisation of Rs 30,607.3 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

In the healthcare sector, Dr. Lal Pathlabs competes with several peers, including Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd. Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,921.65 crore and a P/E ratio of 29.31. Kwality Pharmaceuticals Ltd. boasts a higher ROE of 28.21% and a market cap of Rs 2,815.27 crore. Hikal Ltd. has a P/B ratio of 2.23 and a market cap of Rs 2,738.51 crore. These comparisons highlight Dr. Lal Pathlabs' relative position in terms of market capitalisation and valuation metrics. Investors can use this information to gauge the company's competitive standing within the sector.

Why Investors Are Watching Dr. Lal Pathlabs

Dr. Lal Pathlabs' recent price rise has captured the attention of investors. The stock's performance today, coupled with its market position, makes it a focal point for analysis.

• Price Action: 4.08% increase to Rs 1,880.
• Technical Position: Strong volume participation.
• Fundamental Context: Large Cap with significant market cap.
• Sector Positioning: Operates in a diverse healthcare sector.

Investors should monitor the stock's future movements and sector trends to make informed decisions. Keeping an eye on technical indicators and fundamental metrics will be crucial in assessing potential opportunities.

About Dr. Lal Pathlabs

Dr. Lal Pathlabs is a leading diagnostic and healthcare service provider in India. The company offers a wide range of diagnostic and related healthcare tests and services. It operates through a network of laboratories and patient service centers, providing accessible and reliable healthcare solutions. As a prominent player in the healthcare sector, Dr. Lal Pathlabs is committed to delivering quality diagnostic services to its customers. The company's focus on innovation and technology has positioned it as a trusted name in the industry. Understanding its business model and market position is essential for investors evaluating its long-term potential.

Track Dr. Lal Pathlabs Share Price on Univest

Use Dr. Lal Pathlabs Ltd. (LALPATHLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track Dr. Lal Pathlabs Share Price, along with technical indicators, fundamental ratios, and shareholding patterns, on Univest. The platform provides insights into 52-week levels and market trends, helping investors stay informed about the stock's performance. Univest offers comprehensive tools for analyzing market data and making informed investment decisions.

Frequently Asked Questions

What is Dr. Lal Pathlabs Share Price today?

Ans. Dr. Lal Pathlabs Share Price today is Rs 1,880, reflecting a 4.08% increase from the previous close of Rs 1,806.25. The stock moved 4.08% during the session. The intraday range extended from Rs 1,803.95 to Rs 1,892.

Why did Dr. Lal Pathlabs Share Price rise today?

Ans. The data confirms a 4.08% price rise today, but it does not establish a specific catalyst for this movement. The stock moved 4.08% during the session. The intraday range extended from Rs 1,803.95 to Rs 1,892.

How does Dr. Lal Pathlabs compare to its peers?

Ans. Dr. Lal Pathlabs competes with peers like Dishman Carbogen Amcis Ltd. and Kwality Pharmaceuticals Ltd., with varying market caps and valuation metrics. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.

What is the P/E ratio of the healthcare sector?

Ans. The healthcare sector's P/E ratio ranges from 3.61 to 3439.3, with a median of 26.44, reflecting diverse valuations. The relevant peer median P/E is 26.44x. The peer average P/E is 87.62x.

What are the ROE and ROCE medians in the healthcare sector?

Ans. The healthcare sector's ROE median is 11.07%, and the ROCE median is 13.24%, indicating average profitability and efficiency. The relevant peer median ROE is 11.07%. The relevant peer median ROCE is 13.24%.

How can I track Dr. Lal Pathlabs Share Price?

Ans. You can track Dr. Lal Pathlabs Share Price on Univest, which provides live updates, technical indicators, and market insights. The stock moved 4.08% during the session. The intraday range extended from Rs 1,803.95 to Rs 1,892.